NYC Tech Funding Roundup: Major Capital Injections Led by EliseAI, General Intuition, and TriGemX Bio

The New York City tech ecosystem continues to hum with relentless momentum, proving once again that capital flows freely to enterprises solving complex, high-stakes operational and scientific challenges. Keeping track of every development in such a fast-paced urban innovation hub can be a monumental task for founders, investors, and industry watchers alike. To ensure no critical milestone slips through the cracks, a comprehensive review of the week ending October 3 highlights a diverse array of major venture capital rounds, strategic startup exits, and emerging technological trends spanning artificial intelligence, biotechnology, proptech, robotics, and financial technology.

Among the standout developments are massive late-stage funding rounds for industry leaders like EliseAI and General Intuition, alongside targeted early-stage investments that highlight the enduring strength of the metropolitan area’s startup landscape.

EliseAI – $350M

Leading the week’s headline-grabbing figures is EliseAI, which secured a staggering $350 million in venture funding. The proptech and healthtech automation platform has built a sophisticated system designed to seamlessly handle leasing operations, resident services, and patient intake workflows for housing and healthcare operators. As operational efficiency becomes an increasingly critical priority across property management and medical administration, EliseAI has positioned itself as an indispensable technological partner for large-scale operators.

The hefty funding round was co-led by prominent venture capital powerhouses Andreessen Horowitz and Bessemer Venture Partners, with additional participation coming from institutional heavyweights including the Ontario Teachers’ Pension Plan, Sapphire Ventures, and Navitas Capital. Founded back in 2017 by visionary entrepreneurs Minna Song and Stoyan Stoyanov, EliseAI’s latest influx of capital pushes its cumulative reported equity funding to an impressive $741.9 million. This war chest will likely fuel further product expansion, deep technological scaling, and aggressive market penetration as the company aims to redefine administrative workflows across two massive, traditionally analog industries.

#NYCtech Week in Review: 9/27/26 – 10/3/26

General Intuition – $220M

In the realm of frontier artificial intelligence, General Intuition made massive waves by pulling in $220 million in venture capital. Operating as an advanced AI laboratory, the company focuses on training complex action and world models by leveraging billions of gameplay clips. By studying dynamic virtual environments and strategic interactions, General Intuition aims to build foundational intelligence capable of reasoning and operating within complex physical and digital scenarios.

The funding round was spearheaded by Valor Equity Partners and Atreides Management, drawing strong backing from a high-profile consortium of investors that included Seven Seven Six, Point72, Khosla Ventures, and General Catalyst. Founded recently in 2025 by Moritz Baier-Lentz and Pim de Witte, the burgeoning enterprise has already amassed a total reported equity funding of $673.7 million. The rapid accumulation of capital reflects the intense investor appetite for foundational AI research and teams capable of pushing the absolute boundaries of machine learning capabilities beyond traditional language and vision models.

TriGemX Bio – $94M

Shifting from digital bits to biological molecules, TriGemX Bio secured $94 million in venture funding to advance its pioneering therapeutic pipeline. The biotechnology firm is dedicated to developing a first-in-class oral medicine specifically targeted at the treatment of migraines—a debilitating neurological condition affecting millions worldwide that has long required more effective, accessible, and well-tolerated therapeutic options.

The substantial capital injection was led by a specialized group of life sciences investors, including The Column Group, TCG Crossover, and Viking Global Investors. TriGemX Bio was originally founded in 2015 by renowned scientific leaders Charles Zuker, Richard Axel, and Thomas Maniatis. With this latest round, the company’s total reported equity funding reaches $573 million, providing the financial runway necessary to drive its clinical-stage programs through rigorous trials and closer to potential commercialization.

#NYCtech Week in Review: 9/27/26 – 10/3/26

OuterSignal – $22M Series A

In the consumer intelligence space, OuterSignal announced a $22 million Series A funding round. The platform empowers consumer brands by providing deep insights into customer demographics and behaviors, enabling hyper-personalized marketing strategies tailored to individual buyers.

The financing round was co-led by Long Journey Ventures and Abstract, accompanied by an extensive roster of institutional funds and notable angel investors, including BAM Ventures, Top Shelf Ventures, SuperAngel.Fund, AME Cloud Ventures, Dave Heath, Rohan Shah, Alex Haro, Emery Wells, Kim Perell, Michael Preysman, Michael Perry, Ken Nguyen, Raad Mobrem, Zachary Sims, Sahil Bloom, Steve Carroll, Michael Loeb, Rich Vogel, Troy Osinoff, Sahil Bhaiwala, James Beshara, and Nik Sharma. Founded in 2025 by Zach Zelner and Noah Friedman, OuterSignal aims to leverage the new funding to accelerate its product roadmap and expand its market footprint in data-driven marketing intelligence.

Daptic – $15M Series A

Addressing the often-complex intersection of manufacturing, software, and regulatory compliance, Daptic secured $15 million in Series A funding. The enterprise software platform is designed to help manufacturers seamlessly integrate regulatory requirements directly into their product design and development pipelines, minimizing costly compliance errors and accelerating time-to-market.

The round was led by Canvas Ventures, with ongoing participation from early-stage backers IA Ventures and 8VC. Founded in 2023 by Baptiste Bouvier, Hannah Collins, and Gabby Finear, Daptic has now raised a total of $22 million in reported equity funding. The fresh capital will enable the team to scale its engineering and sales operations to meet rising enterprise demand for automated compliance solutions.

#NYCtech Week in Review: 9/27/26 – 10/3/26

Biotia – $9M Series A Extension

In the specialized field of clinical diagnostics, Biotia successfully raised a $9 million Series A Extension round, a transaction for which AlleyWatch broke the news exclusively. Biotia utilizes advanced metagenomic sequencing technology to accurately identify the underlying infectious causes of recurrent and complicated urinary tract infections, providing clinicians with precise diagnostic data to guide targeted treatments.

The extension round brought together a diverse group of investors, featuring Convergent Ventures, DigitalDx Ventures, Cloquet Capital Partners, Continuum Health Ventures, I-Lab Angels, EGB Capital, Leawood Venture Capital, Red Bear Angels, Red Bear Ventures, Tim Barry, and Clive Fields. Founded in 2016 by Niamh O’Hara, Chris Mason, and Rachid Ounit, Biotia now boasts a total reported equity funding of $19.4 million, bolstering its clinical validation efforts and commercial expansion within the healthtech sector.

Destro AI – $8M Seed

The warehouse automation sector received a boost with Destro AI raising an $8 million Seed round. The software platform acts as a universal orchestrator, coordinating robots, human workers, and enterprise management systems within warehouse environments regardless of the specific hardware brand being deployed.

The funding was led by Base10 Partners and Bonfire Ventures, with additional participation from CoFound Partners. Founded in 2025 by Manthan Pawar, Destro AI addresses a major pain point in supply chain logistics by streamlining interoperability across diverse automated hardware fleets.

#NYCtech Week in Review: 9/27/26 – 10/3/26

Elio Mortgage – $5.1M Pre-Seed

In the fintech arena, Elio Mortgage emerged with $5.1M in Pre-Seed funding in another exclusive report broken by AlleyWatch. The company operates as an AI-native mortgage firm, utilizing an agentic platform to streamline and automate home loan origination and brokerage processes.

The round was led by Motive Partners and Social Leverage, with notable participation from Jeff Horing. Founded in 2026 by Oren Michaely and Arad Lev Ari, Elio Mortgage seeks to modernize the traditionally cumbersome residential lending market through embedded automation and intelligent agent workflows.

F2 AI – $5M

F2 AI, a specialized financial technology firm building agentic AI solutions for credit investors, secured an additional $5 million in venture funding entirely from Golub Capital. The platform is designed to assist financial professionals in screening, underwriting, and monitoring credit deals with greater efficiency and data-driven precision. Founded in 2025 by Don Muir and Emre Kazdagli, F2 AI has now accumulated a total of $29 million in reported equity funding to further develop its financial analytics engine.

Walapay – $4.6M Seed

Cross-border financial infrastructure startup Walapay closed a $4.6 million Seed funding round. The company provides a unified API platform that facilitates account issuance, collections, currency exchange, and global payouts, simplifying international monetary movements for businesses.

#NYCtech Week in Review: 9/27/26 – 10/3/26

The financing round was led by Generative Ventures, alongside participation from Commerce Ventures, Polygon Labs, Verda Ventures, NGC Ventures, FGV Capital, Jsquare, Knollwood Investment Advisory, Big Brain Holdings, Reflexive Capital, and Contribution Capital. Walapay was founded in 2022 by brothers Tom Borgers and Dimitri Borgers.

Tangent Robotics – $4.5M Pre-Seed

Rounding out the week’s funding announcements, Tangent Robotics secured $4.5 million in Pre-Seed capital. The deep-tech robotics startup focuses on developing touch-sensing robotic hands combined with advanced motor learning software, designed to automate delicate, high-precision manufacturing tasks that traditionally require human dexterity.

The round was co-led by Fly Ventures and Toyota Ventures, with supportive backing from Logos Fund and Sparked Ventures. Tangent Robotics was founded in 2025 by Pedro Piacenza, Matei Ciocarlie, and Ioannis Kymissis, setting the stage for advanced deployments in precision industrial automation.

Leave a Reply

Your email address will not be published. Required fields are marked *